top of page

​

Recombinant Human TRAIL/TNFSF10/CD253 (Arg115-Gly281)
Recombinant Human TNF-Related Apoptosis-Inducing Ligand is produced by our E.coli expression system and the target gene encoding Arg115-Gly281 is expressed. Bon Opus Cat. #C022

Recombinant Human TRAIL/TNFSF10/CD253 (Arg115-Gly281)

SKU: C022-10ug
$53.00Price
Quantity
[{"key":"C022-50ug","value":"Backorder"},{"key":"C022-10ug","value":"In Stock"},{"key":"C022-500ug","value":"Backorder"},{"key":"C022-1mg","value":"Backorder"}]

Contact Us

Phone: 800-943-6396 ext#1

Email: orders@bonopusbio.com

Distributors

Shipping Information

$48 Standard Overnight flat rate for products shipped in room temperature within the United States.

 

Additional $27 Ice Packs shipment fee is required for liquid proteins.

 

Please contact us to order for  international shipments.

Endotoxin
Less than 0.1 ng/ug (1 EU/ug) as determined by LAL test.
Accession Number
P50591
Species
Human
Expression System
E.coli
Target Sequence
Arg115-Gly281
Tag
tag free
Formulation
Supplied as a filtered solution of 20mM PB.250mMNacl,Ph7.5.
Packaging
Ambient
Background
Human TNFSF10 is a type II transmembrane protein with an intracellular N-terminus and a ‘TNF homology domain’ (THD) at the extracellular C terminus. TNFSF10 can interact with several distinct receptors. Two of these receptors that belongs to TNFR superfamily, DR4 (TRAIL-R1) and DR5 (TRAIL-R2/TRICK2), are plasma membrane proteins containing intracellular death domains essential for activating apoptosis. TNFSF10 is promising for cancer therapy because it is cytotoxic and activates apoptosis in the majority of malignant cells, but not in normal cells.
Purity
Greater than 95% as determined by reducing SDS-PAGE.
Tumor Necrosis Factor Ligand Superfamily Member 10; Apo-2 Ligand; Apo-2L; TNF-Related Apoptosis-Inducing Ligand; Protein TRAIL; CD253; TNFSF10; APO2L; TRAIL
Alternative Names
Be the first to submit a citation to get publication rewards
Citation
Measured in a cytotoxicity assay using L‑929 mouse fibroblast cells in the presence of the metabolic inhibitor actinomycin D. The ED50 for this effect is 2.5-15 ng/ml.
Activity
bottom of page